Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Two series of factor VIIa inhibitors presented by BMS researchers

Feb. 17, 2004

New prodrugs of thrombin inhibitors covered by LG Life Sciences patent

Feb. 16, 2004

New factor Xa/factor VIIa inhibitors covered by Merck KGaA patent

Feb. 13, 2004

Nuvelo licenses rNAPc from Dendreon

Feb. 9, 2004

The SPORTIF trials provide new data on ximelagatran in the prevention of stroke

Feb. 9, 2004

Aniline-based factor VIIa inhibitors newly identified at BMS

Feb. 5, 2004

Novel carboxypeptidase U inhibitors identified by AstraZeneca researchers

Feb. 3, 2004

Biovitrum to be sole supplier of ReFacto

Jan. 28, 2004

European approval for Mononine continuous intravenous infusion

Jan. 26, 2004

Abciximab and clopidogrel in elective PCI

Jan. 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...